Copyright
©The Author(s) 2017.
World J Cardiol. Mar 26, 2017; 9(3): 255-260
Published online Mar 26, 2017. doi: 10.4330/wjc.v9.i3.255
Published online Mar 26, 2017. doi: 10.4330/wjc.v9.i3.255
n (%) | |
Echo available | 12 |
LV dysfunction | 3/12 (25) |
LVEF (%) (mean ± SD) | 50 ± 16.88 |
Prior LV dysfunction | 1/12 (8.3) |
Asymmetric hypertrophy with mitral SAM | 2/12 (16.67) |
LVH | 7/12 (58.3) |
LVH on ECG | 2/18 (11.1) |
Prolonged QTc | 5/18 (27.78) |
- Citation: Agrawal S, Shirani J, Garg L, Singh A, Longo S, Longo A, Fegley M, Stone L, Razavi M, Radoianu N, Nanda S. Pheochromocytoma and stress cardiomyopathy: Insight into pathogenesis. World J Cardiol 2017; 9(3): 255-260
- URL: https://www.wjgnet.com/1949-8462/full/v9/i3/255.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i3.255